• 1. Acupuncture and Moxibustion Department, Beijing University of Chinese Medicine, Beijing 100105, P. R. China;
  • 2. School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P. R. China;
  • 3. Department of Acupuncture and Moxibustion, Guang’an Men Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, P. R. China;
  • 4. School of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P. R. China;
  • 5. Department of Hospital Medicine, ThedaCare Regional Medical Center, Wisconsin 54911, USA;
  • 6. Department of Chinese Medicine Development, Hong Kong Baptist University, Hong Kong 999077, P. R. China;
  • 7. Department of Biomedical Data Science, Stanford University School of Medicine, California 94305, USA;
  • 8. Virginia University of Integrative Medicine, Virginia 22182, USA;
  • 9. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P. R. China;
  • 10. China Academy of Chinese Medical Sciences, Beijing 100700, P. R. China;
LIU Baoyan, Email: baoyanjournal@163.com; LIU Cunzhi, Email: lcz623780@126.com; YAN Shiyan, Email: yanshiyan@bucm.edu.cn
Export PDF Favorites Scan Get Citation

Objective Sham acupuncture control is a commonly employed method to assess the specific effects of acupuncture in clinical trials. However, due to the absence of specific reporting standards, the reporting quality of sham acupuncture in these trials is low. In order to standardize the reporting of sham acupuncture and improve the reporting quality of sham acupuncture, our project team has developed SHam Acupuncture REporting guidelines and a checklist in clinical trials (SHARE). Methods The development process included four parts: we conducted literature research to form initial items of sham acupuncture reporting; two rounds of Delphi surveys were carried out to evaluate the reporting necessity of these initial items; two expert consensus meetings were held to further discuss and agree upon the Delphi results and approve the SHARE checklist; a pilot testing was conducted to assess the feasibility and practicality of the list and make necessary revisions to generate the final SHARE checklist. Results The SHARE checklist consisted of 10 categories with 19 items. The requirements for reporting sham acupuncture primarily focused on sham acupuncture detailed information as well as relevant background factors. Conclusion The SHARE serves as specialized reporting guidelines for sham acupuncture that offers clear guidance on comprehensive and concise reporting of sham acupuncture.

Citation: LIU Xiaoyu, MA Peihong, LIU Zhishun, GUO Yi, ZHOU Kehua, BIAN Zhaoxiang, SUN Chengyi, LIU Tinglan, XIONG Zhiyi, XIE Yixuan, LU Ying, LAO Lixing, HE Liyun, LIU Baoyan, LIU Cunzhi, YAN Shiyan, SHARE Workgroup. Sham acupuncture reporting guidelines and a checklist in clinical trials. Chinese Journal of Evidence-Based Medicine, 2024, 24(7): 745-750. doi: 10.7507/1672-2531.202403003 Copy

  • Next Article

    Guidelines for the diagnosis and treatment of uterine prolapse with traditional Chinese medicine (revised): a protocol